Lluís Masana Marín-rekin lankidetzan egindako argitalpenak (8)

2024

  1. Alteraciones del metabolismo de las lipoproteínas.

    Medicina interna (Elsevier España), pp. 1901-1927

2020

  1. Alteraciones del metabolismo de las lipoproteínas

    Medicina interna [19ª ed.] (Elsevier España)

2015

  1. Estimating cardiovascular risk in Spain by the European guidelines on cardiovascular disease prevention in clinical practice

    Revista Espanola de Cardiologia, Vol. 68, Núm. 5, pp. 417-425

2014

  1. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clínica e investigación en arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  2. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  3. The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice

    Atherosclerosis Supplements, Vol. 15, Núm. 1, pp. 1-15

2004

  1. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

    Atherosclerosis, Vol. 173, Núm. 1, pp. 55-68

2002

  1. A proposal to redefine familial combined hyperlipidaemia - Third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European society for clinical investigation

    European Journal of Clinical Investigation